natgillin/translations-raw huggingface dataset:
Lonsurfs virkning og sikkerhed blev sammenlignet mellem en højeksponerings-gruppe (> median) og en laveksponerings-gruppe (≤ median) baseret på median-AUC for trifluridin.
The efficacy and safety of Lonsurf was compared between a high-exposure group (>median) and a low-exposure group (≤median) based on the median AUC value of trifluridine.
Lonza Biologics Inc., 101 International Drive, Portsmouth, NH 03801-2815, USA Navn og dresse på de fremstillere, der er ansvarlige for batchfrigivelse
Lonza Biologics Inc., 101 International Drive, Portsmouth, NH 03801-2815, USA Name and address of the manufacturers responsible for batch release
Lonza Biologics, Inc.‌
Lonza Biologics, Inc.
Lonza Biologics, plc.
Smithfield, Rhode Island 02917 U.S.A.
Loperamid 16 mg x 1
Loperamide 16 mg QD
Loperamid AUC ↓ 51%
Loperamide AUC ↓ 51
Loperamid blev givet til 13 % af patienterne i 5 % af behandlingsperioderne.
Loperamide was administered to 13 % of patients in 5 % of courses.
Loperamid Cmax ↓ 61%
Loperamide Cmax ↓ 61
Loperamid Cmax ↓ 61%
Loperamide Cmax ↓ 61% Loperamide AUC ↓ 51
Lopinavir + ritonavir/ dolutegravir
Lopinavir+ritonavir/ Dolutegravir
lopinavir 400 mg og ritonavir 100 mg to gange dagligt
lopinavir 400 mg and ritonavir 100 mg twice daily
Lopinavir AUC over et 12 timers doseringsinterval var i gennemsnit 113,2  60,5 gh/ml.
Lopinavir AUC over a 12 hour dosing interval averaged 113.2 ± 60.5 μg•h/ml.
lopinavir AUC ↓ 34 %
lopinavir AUC ↓ 34
lopinavir AUC ↔ lopinavir Cmin ↓ 11 % lopinavir Cmax ↔ rilpivirin AUC ↑ 52 % rilpivirin Cmin ↑ 74 % rilpivirin Cmax ↑ 29 % (hæmning af CYP3A-enzymer)
lopinavir AUC ↔ lopinavir Cmin ↓ 11% lopinavir Cmax ↔ rilpivirine AUC ↑ 52% rilpivirine Cmin ↑ 74% rilpivirine Cmax ↑ 29% (inhibition of CYP3A enzymes)
Lopinavir bindes både til alfa-1- syre glucoprotein (AAG) og albumin, men har støre affinitet overfor AAG .
Lopinavir binds to both alpha- 1-acid glycoprotein (AAG) and albumin, however, it has a higher affinity for AAG.
Lopinavir bindes både til alfa-1- syre glucoprotein (AAG) og albumin, men har støre affinitet overfor AAG .
Lopinavir binds to both alpha-1-acid glycoprotein (AAG) and albumin however, it has a higher affinity for AAG.
Lopinavir boostet med ritonavir (4 x
Lopinavir boosted with ritonavir (4x200 mg/
lopinavir Cmaks. ↓ 30 %
lopinavir Cmax ↓ 30
lopinavir Cmin ↓ 43 %
lopinavir Cmin ↓ 43
Lopinavir formuleret sammen med ritonavir (lopinavir/ritonavir) 400 mg/100 mg eller 800 mg/200 mg
Lopinavir co-formulated with ritonavir (lopinavir/ritonavir) 400 mg/100 mg or 800 mg/200 mg.
Lopinavir formuleret sammen med ritonavir (lopinavir/ritonavir) 400 mg/100 mg eller 800 mg/200 mg
Lopinavir co-formulated with ritonavir (lopinavir/ritonavir) 400 mg/100 mg or 800 mg/200mg.
Lopinavir gennemsnitlig steady-state AUC, Cmax og Cmin var henholdsvis 72,6  31,1 gh/ml, 8,2  2,9 g/ml og 3,4  2,1 g/ml efter Kaletra 230/57,5 mg/m2 to gange dagligt uden nevirapin (n=12) og var henholdsvis 85,8  36,9
The lopinavir mean steady- state AUC, Cmax, and Cmin were 72.6  31.1 gh/ml, 8.2  2.9 g/ml and 3.4  2.1 g/ml, respectively after Kaletra oral solution 230/57.5 mg/m2 twice daily without nevirapine (n=12), and were
Lopinavir gennemsnitlig steady-state AUC, Cmax og Cmin var henholdsvis 72,6  31,1 gh/ml, 8,2  2,9 g/ml og 3,4  2,1 g/ml efter Kaletra 230/57,5 mg/m2 to gange dagligt uden nevirapin (n=12) og var henholdsvis 85,8  36,9
The lopinavir mean steady-state AUC, Cmax, and Cmin were 72.6  31.1 gh/ml, 8.2  2.9 g/ml and 3.4  2.1 g/ml, respectively after Kaletra 230/57.5 mg/m2 twice daily without nevirapine (n=12), and were 85.8  36.9 gh/ml,
Lopinavir giver lopinavir/ritonavir dets antivirale effekt.
Lopinavir provides the antiviral activity of lopinavir/ritonavir.
Lopinavir og ritonavir er stærkt proteinbundne, derfor er det usandsynligt, at de vil blive fjernet i signifikante mængder under hæmodialyse eller peritoneal dialyse.
Because lopinavir and ritonavir are highly protein bound, it is unlikely that they will be significantly removed by haemodialysis or peritoneal dialysis.
Lopinavir+ritonavir (og andre ritonavir-boostede proteaseinhibitorer): Samtidig administration af bosentan 125 mg to gange dagligt og lopinavir+ritonavir 400 +100 mg to gange dagligt i 9,5 dage til raske forsøgspersoner medførte initiale dalkoncentrationer af bosentan, som var omtrent 48 gange højere end de koncentrationer, der blev målt efter administration af bosentan alene.
Lopinavir+ritonavir (and other ritonavir-boosted protease inhibitors): co-administration of bosentan 125 mg twice daily and lopinavir+ritonavir 400+100 mg twice daily for 9.5 days in healthy volunteers resulted in initial trough plasma concentrations of bosentan that were approximately 48-fold higher than those measured after bosentan administered alone.
Lopinavir- ritonavir-niveauerne kan stige ved stop af behandling med perikon.
Lopinavir and ritonavir levels may increase on stopping St John’s wort.
Lopinavir-ritonavir-niveauerne kan stige ved stop af behandling med perikon.
Lopinavir and ritonavir levels may increase on stopping St John’s wort.
Lopinavir/ritonavir
Lopinavir/ritonavir (oral solution) 300/75 mg/m2 BID
Lopinavir/ritonavir (blød gelkapsel)*# 400/100 mg x 2
Lopinavir/ritonavir (soft gel capsule)*# 400/100 mg twice daily
Lopinavir/ritonavir (Kaletra): I en åben ikke-fastende farmakokinetisk undersøgelse mindskedes AUC, Cmax og Cmin for lopinavir med henholdsvis 38 %, 28 % og 52 %, da amprenavir (750 mg 2 gange daglig) blev givet i kombination med Kaletra (400 mg lopinavir + 100 mg ritonavir 2 gange daglig).
Lopinavir / ritonavir (Kaletra): in an open-label, non-fasting pharmacokinetic study, the AUC, Cmax and Cmin of lopinavir were decreased by 38%, 28% and 52% respectively when amprenavir (750 mg twice daily) was given in combination with Kaletra (400 mg lopinavir + 100 mg ritonavir twice daily).
Lopinavir/ritonavir (oral opløsning) 300/75 mg/m2 to gange daglig
Lopinavir/ritonavir (oral solution) 300/75 mg/m2 BID
Lopinavir/ritonavir -tabletter kan tages sammen med eller uden mad.
Lopinavir/ritonavir tablets can be taken with or without food.
lopinavir/ritonavir 400
lopinavir/ritonavir
Lopinavir/ritonavir 400/100 mg x 2
Lopinavir/ritonavir
Lopinavir/ritonavir 400/100 mg x 2 + OBR
Lopinavir/ritonavir 400/100 mg twice daily + OBR
lopinavir/ritonavir 400mg/100 mg
lopinavir/ritonavir
Lopinavir/ritonavir 533/133,3 mg x 2
400/100 mg twice daily
Lopinavir/ritonavir 800/200 mg blev administreret i kombination med emtricitabin 200 mg og tenofovir DF 300 mg, som en del af et regime med administration en gang dagligt.
Lopinavir/ritonavir 800/200 mg was administered in combination with emtricitabine 200 mg and tenofovir DF 300 mg as part of a once daily regimen.
lopinavir/ritonavir blød
exposure.
Lopinavir/ritonavir bløde
Nelfinavir:
Lopinavir/ritonavir bløde kapsler eller
Lopinavir/ritonavir soft capsules or
lopinavir/ritonavir bør dosis af
lopinavir/ritonavir, the dose of
lopinavir/ritonavir bør undgås på
adverse events, the combination of
lopinavir/ritonavir bør undgås på grund
related adverse events, the
lopinavir/ritonavir foretages med
lopinavir/ritonavir must be done with
lopinavir/ritonavir forhøjer
hown to significantly increase
lopinavir/ritonavir forårsager
causes a similar increase in
lopinavir/ritonavir forårsager lignende
combination of lopinavir/ritonavir
Lopinavir/ritonavir indeholder de aktive stoffer lopinavir og ritonavir.
Lopinavir/Ritonavir Mylan contains the active substances lopinavir and ritonavir.
lopinavir/ritonavir kan
lopinavir/ritonavir can be
Lopinavir/ritonavir kan anvendes af børn fra 2 år, unge og voksne, der er smittet med hiv, som er den virus, der forårsager aids.
Lopinavir/ritonavir is used by children 2 years of age or older, adolescents and adults who are infected with HIV, the virus which causes AIDS.
Lopinavir/ritonavir kan forårsage ændringer i din hjerterytme og i den elektriske aktivitet i hjertet.
Lopinavir/ritonavir may cause changes in your heart rhythm and the electrical activity of your heart.
Lopinavir/ritonavir koncentrationer er ikke undersøgt.
Lopinavir/ritonavir concentrations not
Lopinavir/Ritonavir Mylan 100 mg/25 mg filmovertrukne tabletter
Lopinavir/Ritonavir Mylan 100 mg/25 mg film-coated tablets
Lopinavir/Ritonavir Mylan 100 mg/25 mg filmovertrukne tabletter lopinavir/ritonavir
Lopinavir/Ritonavir Mylan 100 mg/25 mg film-coated tablets lopinavir/ritonavir
Lopinavir/Ritonavir Mylan 200 mg/50 mg filmovertrukne tabletter
Lopinavir/Ritonavir Mylan 200 mg/50 mg film-coated tablets
Lopinavir/Ritonavir Mylan 200 mg/50 mg filmovertrukne tabletter er hvide, ovale, bikonvekse, filmovertrukne tabletter med afskåret kant mærket med “MLR3” på den ene side og uden mærkning på den anden side.
Lopinavir/Ritonavir Mylan 200 mg/50 mg film-coated tablets are white, film coated, ovaloid, biconvex beveled edge tablets debossed with 'MLR3' on one side of the tablet and plain on the other side.
Lopinavir/Ritonavir Mylan 200 mg/50 mg filmovertrukne tabletter lopinavir/ritonavir
Lopinavir/Ritonavir Mylan 200 mg/50 mg film-coated tablets lopinavir/ritonavir
Lopinavir/Ritonavir Mylan-tabletterne indeholder lopinavir og ritonavir, der begge hæmmer P450- isoformen CYP3A.
Lopinavir/Ritonavir Mylan tablets contain lopinavir and ritonavir, both of which are inhibitors of the P450 isoform CYP3A.
Lopinavir/ritonavir må ikke gives til disse patienter. (se pkt.
Lopinavir/ritonavir must not be given to these patients (see section 4.3).
Lopinavir/ritonavir må ikke indgives en gang dagligt i kombination med carbamazepin og phenobarbital.
Lopinavir/ritonavir must not be administered once daily in combination with carbamazepine and phenobarbital.
Lopinavir/ritonavir må ikke indgives en gang dagligt i kombination med phenytoin.
Lopinavir/ritonavir must not be administered once daily in combination with phenytoin.
Lopinavir/ritonavir må ikke tages en gang daglig med efavirenz, nevirapin, carbamazepin, phenobarbital og fenytoin.
Lopinavir/ritonavir must not be taken once daily with efavirenz, nevirapine, carbamazepine, phenobarbital and phenytoin.
Lopinavir/ritonavir må ikke tages en gang daglig med efavirenz, nevirapin, carbamazepin, phenobarbital og phenytoin.
Lopinavir/ritonavir must not be taken once daily with efavirenz, nevirapine, carbamazepine, phenobarbital and phenytoin.
Lopinavir/ritonavir nedsætter ikke risikoen for at smitte andre med hiv.
Lopinavir/ritonavir does not reduce the risk of passing HIV to others.
lopinavir/ritonavir og boceprevir
administer lopinavir/ritonavir and
lopinavir/ritonavir og bosentan.
for bosentan toxicity, especially
lopinavir/ritonavir og simeprevir
administer lopinavir/ritonavir and simeprevir.
lopinavir/ritonavir og tadalafil
lopinavir/ritonavir with tadalafil is
lopinavir/ritonavir og Victrelis
co-administer
Lopinavir/ritonavir ordineres til brug i kombination med andre antivirale lægemidler.
Lopinavir/ritonavir is prescribed for use in combination with other antiviral medicines.
lopinavir/ritonavir.
co-administration with
lopinavir/ritonavir.
Lopinavir:
lopinavir/ritonavir.
with lopinavir/ritonavir.
Lopinavir/ritonavir/ tenofovirdisoproxilfumarat (400 mg b.i.d./100 mg b.i.d./300 mg q.d.)
Lopinavir/ritonavir/Tenofovir disoproxil fumarate (400 mg b.i.d./100 mg b.i.d./300 mg q.d.)
Lopinavir/ritonavirs
Bosentan:
Lopinavir/ritonavirtabletter/efavirenz
Indinavir/Efavirenz
Lopinavir/ritonavirtabletter/efavirenz
the lopinavir/ritonavir soft
Lopinavir:
inhibition by Kaletra.
Lopinavir:
Tacrolimus
Lopinavir:
with lopinavir/ritonavir.
Lopinavir: AUC: ↓ 34%
Lopinavir: ↔
Lopinavir: Cmax 30 % Lopinavir: AUC  37 % Lopinavir: Cmin  52 %
Lopinavir: AUC  37% Lopinavir: Cmin  52
Lopinavir: Koncentrationerne kan være nedsat på grund af CYP3A- induktion af dexamethason.
Due to CYP3A inhibition by lopinavir/ritonavir.
Lopinavir: ↔
More frequent therapeutic
Lopinavirkoncentrationer:
Lopinavir/ritonavir tablets/ Efavirenz
Lopinavirkoncentrationer: ↓ 30-40%
Lopinavir concentrations: ↓ 30-40
Lopinavirs effektive halveringstid (fra maksimum til minimum) over et doseringsinterval på 12 timer er i gennemsnit 5-6 timer, og lopinavirs tilsyneladende orale clearance (CL/F) er 6 til 7 l/t.
The effective (peak to trough) half-life of lopinavir over a 12 hour dosing interval averaged 5 – 6 hours, and the apparent oral clearance (CL/F) of lopinavir is 6 to 7 l/h.
Lopinavirs gennemsnitlige + standardafvigelse for AUC, Cmax og C12 ved steady-state var henholdsvis 112,5 + 37,1 µg∙time/ml, 12,4 + 3,5 µg/ml og 5,71 + 2,99 µg/ml.
The lopinavir mean ± standard deviation steady-state AUC, Cmax and C12 were 112.5 ± 37.1 μgh/ml, 12.4 ± 3.5 μg/ml and 5.71 ± 2.99 μg/ml, respectively.
Lopinvir/ritonavirtabletter/efavirenz
Lopinavir/ritonavir tablets/
Loppe  Hjerteorm
Flea  Heartworm
Loppe behandling og forebyggelse
Flea treatment and prevention
Loppe Hjerteorm
Flea Heartworm
Loppe larve Otodectes
Flea larvae Otodectes
Loppe larve Sarcoptes
Flea larvae Sarcoptes
Loppe Otodectes
Flea Otodectes
Loppebehandling og -forebyggelse
Flea treatment and prevention
Loppelarver i dyrets omgivelser bliver dræbt efter kontakt med et dyr, der er behandlet med dette produkt.
Flea larvae in the pet’s surroundings are killed after contact with a pet treated with the product.
Loppelarver i dyrets omgivelser bliver dræbt ved kontakt med et dyr, der er behandlet med dette produkt.
Flea larvae in the pet’s surroundings are killed after contact with a pet treated with the product.
Loppens forskellige udviklingsstadier, der findes i hundens nærmeste omgivelser, bliver dræbt, når de kommer i kontakt med Activyl-behandlede dyr.
Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl treated pets.
Loppens forskellige udviklingsstadier, der findes i kattens nærmeste omgivelser, bliver dræbt, når de kommer i kontakt med Activyl-behandlede dyr.
Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl treated pets.
Loppens forskellige udviklingsstadier, der findes i kæledyrets nærmeste omgivelser, bliver dræbt når de kommer i kontakt med Activyl Tick Plus-behandlede hunde.
Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl Tick Plus treated pets.
Loppens forskellige udviklingsstadier, der findes i kæledyrets nærmeste omgivelser, bliver dræbt når de kommer i kontakt med Activyl Tick Plus-behandlede kæledyr.
Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl Tick Plus treated pets.
Loppens forskellige udviklingsstadier, der findes i kæledyrets nærmeste omgivelser, bliver dræbt, når de kommer i kontakt med Activyl-behandlede dyr.
Developing stages of fleas in the pet’s immediate surroundings are killed following contact with Activyl treated pets.
Lopper dræbes inden for 24 timer.
Elimination of fleas within 24 hours.
Lopper fra kæledyr infesterer ofte dyrets kurv, leje og sædvanlige hvilesteder, såsom tæpper og bløde møbler.
Fleas from pets often infest animal’s basket, bedding and regular resting areas such as carpets and soft furnishings.
Lopper fra kæledyr infesterer ofte dyrets kurv, leje og sædvanlige hvilesteder, såsom tæpper og bløde møbler.
Fleas from pets often infest the animal’s basket, bedding and regular resting areas such as carpets and soft furnishings.
Lopper kan infestere hundens kurv, underlag og sædvanlige opholdssteder som gulvtæpper og bløde møbler.
Fleas can infest the dog’s basket, bedding and regular resting areas such as carpets and soft furnishings.
Lopper kan infestere kattens kurv, underlag og sædvanlige opholdssteder som gulvtæpper og bløde møbler.
Fleas can infest the cat’s basket, bedding and regular resting areas such as carpets and soft furnishings.
Lopper og flåter skal bide sig fast på værtsdyret og starte indtag af føde for at blive udsat for det aktive stof.
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
Lopper og flåter skal sætte sig på værten og begynde at æde for at blive udsat for det aktive stof.
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
Lopper og flåter skal sætte sig på værten og starte fødeindtag, før de udsættes for det aktive stof.
Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
Loratadin Ritonavir doseret som en farmakokinetisk forstærker eller som et antiretroviralt stof hæmmer CYP3A og forventes som følge heraf at øge plasmakoncentrationen af loratidin.
Loratadine Ritonavir dosed as a pharmacokinetic enhancer or as an antiretroviral agent inhibits CYP3A and as a result is expected to increase the plasma concentrations of loratadine.
lorazepam – (anvendes til behandling af angst) alkohol
lorazepam (used for treating anxiety). alcohol.
Los cambios propuestos de las secciones 4.6 y 4.8 del RCP y del prospecto se indican en el Anexo 1 de este informe de evaluación.
The proposed changes to sections 4.6 and 4.8 of the SmPC and the leaflet are detailed in Annex 1 of this assessment report.
Los comprimidos recubiertos con película de 100 mg de Siklos son redondos y casi blancos.
Siklos 100 mg film-coated tablets are off-white, round tablets.
Los comprimidos rotos sin usar de Siklos 1000 mg deben introducirse de nuevo en la caja y deben ser usados en tres meses.
Unused Siklos 1000 mg broken tablets must be replaced in the bottle and must be used within three months.
Los datos clínicos obtenidos en pacientes con anemia drepanocítica no han aportado pruebas de que la hidroxicarbamida produzca reacciones adversas para las funciones hepática y renal.
The clinical data obtained in patients with Sickle Cell Syndrome have not shown evidence of adverse reactions of hydroxycarbamide on hepatic and renal function.
Los datos existentes sobre el tratamiento con hidroxicarbamida en niños menores de 2 años de edad son tan escasos que no se han establecido pautas de administración y, por tanto, no se recomienda el tratamiento con hidroxicarbamida de esta población.
Because of the rarity of data on treatment with hydroxycarbamide in children less than 2 years of age, dose regimens have not been established and thus, in this population, the treatment with hydroxycarbamide is not recommended.
Los demás componentes son estearil fumarato de sodio, celulosa microcristalina con sílice y copolímero de metacrilato.
The other ingredients are sodium stearyl fumarate, silicified microcrystalline cellulose and methacrylate copolymer.
Los estudios en animales han mostrado toxicidad para la reproducción (ver sección 5.3). ).
Studies in animals have shown reproductive toxicity (see section 5.3).
Los intervalos tóxicos de mielosupresión se recogen en la sección 4.2. Lactancia (ver sección 4.6).
Toxic ranges of myelosuppression as described in section 4.2. Breast-feeding (see section 4.6).
Los medicamentos no se deben tirar por los desagües ni a la basura.
Do not throw away any medicines via wastewater or household waste.
Los pacientes en tratamiento con hidroxicarbamida deben ser avisados de los riesgos teóricos en el feto.
Patients on hydroxycarbamide should be made aware of the theoretical risks to the foetus.
Los pacientes en tratamiento con hidroxicarbamida quienes deseen concebir un hijo, deben interrumpir el tratamiento entre 3 y 6 meses antes del embarazo, si es posible.
Patients on hydroxycarbamide wishing to conceive should stop treatment 3 to 6 months before pregnancy if possible.
Los pacientes en tratamiento con hidroxicarbamida; quienes deseen concebir un hijo, deben interrumpir el tratamiento entre 3 y 6 meses antes del embarazo, si es posible.
Patients on hydroxycarbamide wishing to conceive should stop treatment 3 to 6 months before pregnancy if possible.
Los pacientes que se estabilicen con dosis inferiores serán controlados cada 2 meses.
Patients who are stable on lower doses should be monitored every 2 months.
Los pacientes y los padres o tutores deben ser capaces de seguir las instrucciones de administración de este medicamento, de su control y su cuidado.
Patients and/or parents or the legal responsible person must be able to follow directions regarding the administration of this medicinal product, their monitoring and care.
Los resultados preliminares mostraron que existe un deterioro estadísticamente significativo en todos los parámetros de semen después de una terapia de 6 meses con HU.
The preliminary results show that there is a statistically significant impairment in all sperm parameters after a 6 months HU therapy.
Los síntomas más frecuentes de la sobredosis de Siklos son:
The most common symptoms of overdose with Siklos are:
Los valores respectivos del aclaramiento total en niños fueron de 7,25 l/h (0,20 l/h/kg), 2,91 por vía renal y
The respective value for total clearance in children was 7.25 l/h (0.20 l/h/kg) with 2.91 and 4.34 l/h by renal and non-renal pathways.
Losartan (anvendes til at behandle højt blodtryk),
losartan (used to treat high blood pressure),
Losartan og andre AIIRAer (angiotensin II-receptor-antagonister)
Losartan and other AIIRAs (Angiotensin II Receptor Antagonists)
Lot
13.
Lot (nummer)
Lot {number}
Lot Lot, se side 1 Lot, se bagsiden
Lot Lot see page 1 Lot see reverse
Lot no:
Lot
Lot nr.:
Lot:
Lot nummer
Lot {number}
Lot Solvens lot
Batch Solvent Batch
Lot Vnr.
Lot
Lot {nummer}
Batch {number}
Lot {nummer}
Batch{number}
Lot {nummer}
Lot (Number)
Lot {nummer}
Lot:
Lot {nummer}
Lot: {number}
Lot {nummer}
Lot:{number}
Lot {nummer}.
Lot {number}
Lot, {nummer}
Lot{number}
Lot,{nummer}
Lot {number}
Lot-nummer/identitetskæde
Lot /COI {lot number/chain of identity}
Lot-nummer/identitetskæde
Lot/COI {lot number/chain of identity}
Lot. {nummer}
Lot {number}
LOT.:
Lot
Lot/Batch {nummer}
Lot/Batch {number}
Lot: Se modsatte side
Lot: see reverse
Lot: {Lotnummer}
Lot: {lot number}
Lot: {Lotnummer} Biopsi: {Biopsinr.}
Lot: {lot number} Biopsy: {biopsy number}
Lot: {nummer}
Batch {number}
Lot: {nummer}
Lot {number}
Lot: {nummer}
Lot{number}
Lot: {nummer} for pulveret: Lot: {nummer} for solvensen:
Lot: {number} for the powder: Lot: {number} for the solvent:
LOT:.
Lot
Lot:.
Lot:
Lote
Lot
Lote:
Lot
Lotnummer
Lot {number}
Lotnummer: Hætteglas nr: xxx
Vial No: xxx
Lot{nummer}
BN{number}
Lot{nummer}
Lot:{number}
Lot{nummer}
Lot{number}
lovastatin eller simvastatin – anvendes til at sænke kolesterol i blodet perikon (Hypericum perforatum) – naturlægemiddel til behandling af depression
St. John's wort (Hypericum perforatum) - a herbal medicine used for depression
Lovastatin og simvastatin
Ethinyl Oestradiol
Lovastatin og simvastatin
Lovastatin and Simvastatin
Lovastatin, rosuvastatin og simvastatin er
Lovastatin, rosuvastatin and simvastatin are
lovastatin, simvastatin (anvendes til at sænke kolesterol i blodet)
lovastatin, simvastatin (used to lower blood cholesterol)
lovastatin, simvastatin (til behandling af forhøjet kolesterol i blodet)
lovastatin, simvastatin (used to lower cholesterol)
lovastatin, simvastatin - bruges til at behandle højt niveau af fedt i blodet
lovastatin, simvastatin – used to treat high level of fats in blood;
lovastatin, simvastatin, anvendes til at sænke kolesterol i blodet
lovastatin, simvastatin, used to lower blood cholesterol
Lovastatin, simvastatin: Markant forøgede plasma- koncentrationer på grund af Kaletras hæmning af CYP3A.
Lovastatin, Simvastatin: Markedly increased plasma concentrations due to CYP3A inhibition by Kaletra.
Lovastatin, simvastatin: Markant forøgede plasma- koncentrationer på grund af lopinavir/ritonavirs hæmning af CYP3A.
Markedly increased plasma concentrations due to CYP3A inhibition by lopinavir/ritonavir.
Loxicom 0,5 mg/ml oral suspension til hunde.
Loxicom 0.5 mg/ml oral suspension for dogs
Loxicom 0,5 mg/ml oral suspension til kat
Loxicom 0.5 mg/ml Oral Suspension for Cats.
Loxicom 0,5 mg/ml oral suspension til katte forhandles i en 5 ml, 15 ml og 30 ml pakning.
Loxicom 0.5 mg/ml Oral Suspension for Cats is available in 5 ml, 15 ml and 30 ml volumes.
Loxicom 1 mg, tyggetabletter til hunde EU/2/08/090/019 – 1 x 10 tabletter EU/2/08/090/020 – 2 x 10 tabletter
Loxicom 1 mg chewable tablets for dogs: EU/2/08/090/019 – 1 x 10 tablets EU/2/08/090/020 – 2 x 10 tablets